A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer

被引：0

作者：

Folefac Aminkeng

Amit P Bhavsar

Henk Visscher

Shahrad R Rassekh

Yuling Li

Jong W Lee

Liam R Brunham

Huib N Caron

Elvira C van Dalen

Leontien C Kremer

Helena J van der Pal

Ursula Amstutz

Michael J Rieder

Daniel Bernstein

Bruce C Carleton

Michael R Hayden

Colin J D Ross

机构：

[1] Centre for Molecular Medicine and Therapeutics,Department of Medical Genetics

[2] University of British Columbia,Department of Pediatrics, Division of Translational Therapeutics

[3] Child and Family Research Institute,Department of Pediatrics

[4] University of British Columbia,Department of Pediatrics, Division of Pediatric Hematology/Oncology/Blood and Marrow Transplantation

[5] Amalia Children's Hospital,Department of Pediatric Oncology

[6] Radboud University Medical Center,Department of Medical Oncology

[7] University of British Columbia,Department of Pediatrics

[8] Translational Laboratory in Genetic Medicine,Division of Pediatric Cardiology

[9] National University of Singapore and Association for Science,undefined

[10] Technology and Research (A*STAR),undefined

[11] Emma Children's Hospital/Academic Medical Center,undefined

[12] Emma Children's Hospital/Academic Medical Center,undefined

[13] University of Western Ontario,undefined

[14] Stanford University,undefined

[15] Pharmaceutical Outcomes Programme,undefined

[16] British Columbia Children's Hospital,undefined

[17] Alberta Children's Hospital,undefined

[18] Calgary,undefined

[19] Stollery Children's Hospital,undefined

[20] Edmonton,undefined

[21] Winnipeg Health Sciences Centre,undefined

[22] London Health Sciences Centre,undefined

[23] McMaster Children's Hospital,undefined

[24] Hospital for Sick Children,undefined

[25] Kingston General Hospital,undefined

[26] Children's Hospital of Eastern Ontario,undefined

[27] CHU Sainte-Justine,undefined

[28] McGill University Health Centre–Montréal Children's Hospital,undefined

[29] IWK Health Centre,undefined

[30] Halifax,undefined

[31] Janeway Children's Hospital,undefined

[32] St. John's,undefined

[33] Present address: Institute of Clinical Chemistry,undefined

[34] Inselspital Bern University Hospital,undefined

[35] and University of Bern,undefined

[36] Bern,undefined

[37] Switzerland.,undefined

来源：

Nature Genetics | 2015年 / 47卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Colin Ross and colleagues report the results of a genome-wide association study of anthracycline-induced cardiotoxicity in children treated for cancer. They identify a nonsynonymous coding variant in RARG associated with roughly fivefold higher risk of developing this severe adverse drug reaction.

引用

页码：1079 / 1084

页数：5

共 50 条

[21] Exome array analysis identifies GPR35 as a novel susceptibility gene for anthracycline-induced cardiotoxicity in childhood cancer [J].

Ruiz-Pinto, Sara ;

Pita, Guillermo ;

Patino-Garcia, Ana ;

Alonso, Javier ;

Perez-Martinez, Antonio ;

Carton, Antonio J. ;

Gutierrez-Larraya, Federico ;

Alonso, Maria R. ;

Barnes, Daniel R. ;

Dennis, Joe ;

Michailidou, Kyriaki ;

Gomez-Santos, Carmen ;

Thompson, Deborah J. ;

Easton, Douglas F. ;

Benitez, Javier ;

Gonzalez-Neira, Anna .

PHARMACOGENETICS AND GENOMICS, 2017, 27 (12) :445-453

[22] Genotyping the risk of anthracycline-induced cardiotoxicity [J].

Deng, Shiwei ;

Wojnowski, Leszek .

CARDIOVASCULAR TOXICOLOGY, 2007, 7 (02) :129-134

[23] Genotyping the risk of anthracycline-induced cardiotoxicity [J].

Shiwei Deng ;

Leszek Wojnowski .

Cardiovascular Toxicology, 2007, 7 :129-134

[24] Risk Factors for Anthracycline-Induced Cardiotoxicity [J].

Qiu, Shuo ;

Zhou, Tian ;

Qiu, Bo ;

Zhang, Yuxin ;

Zhou, Yonggang ;

Yu, Huihui ;

Zhang, Jingyi ;

Liu, Li ;

Yuan, Lijun ;

Yang, Guodong ;

Duan, Yunyou ;

Xing, Changyang .

FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8

[25] New Developments in Anthracycline-Induced Cardiotoxicity [J].

Mordente, A. ;

Meucci, E. ;

Silvestrini, A. ;

Martorana, G. E. ;

Giardina, B. .

CURRENT MEDICINAL CHEMISTRY, 2009, 16 (13) :1656-1672

[26] Drug transporters and anthracycline-induced cardiotoxicity [J].

Huang, Kevin M. ;

Hu, Shuiying ;

Sparreboom, Alex .

PHARMACOGENOMICS, 2018, 19 (11) :883-888

[27] Anthracycline-induced cardiotoxicity in children with malignancies [J].

Godoy, LY ;

Fukushige, J ;

Igarashi, H ;

Matsuzaki, A ;

Ueda, K .

ACTA PAEDIATRICA JAPONICA, 1997, 39 (02) :188-193

[28] Natriuretic peptides in anthracycline-induced cardiotoxicity [J].

Perik, PJ ;

van Veldhuisen, DJ ;

Gietema, JA .

EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (05) :940-941

[29] Early detection of anthracycline-induced cardiotoxicity [J].

Feng, Weimin ;

Wang, Qingchen ;

Tan, Yuan ;

Qiao, Jiao ;

Liu, Qi ;

Yang, Boxin ;

Yang, Shuo ;

Cui, Liyan .

CLINICA CHIMICA ACTA, 2025, 565

[30] THE HEART OF THE MATTER: ANTHRACYCLINE-INDUCED CARDIOTOXICITY [J].

Schulte, Sarah ;

Middendorf, Matthew ;

McLeroy, Robert .

CHEST, 2021, 160 (04) :105A-105A

← 1 2 3 4 5 →